Section Arrow
Quote
RVTY.NYSE
- Revvity
Quotes are at least 15-min delayed:2025/07/02 13:46 EDT
Last
 100.26
+1.23 (+1.24%)
Day High 
100.85 
Prev. Close
99.03 
1-M High
102.18 
Volume 
320.99K 
Bid
100.13
Ask
100.29
Day Low
98.82 
Open
99.635 
1-M Low
87.7 
Market Cap 
11.67B 
Currency USD 
P/E 40.92 
%Yield 0.35 
10-SMA 96.5 
20-SMA 95.08 
50-SMA 93.57 
52-W High 129.5 
52-W Low 87.7 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.34/5.82
Enterprise Value
14.97B
Balance Sheet
Book Value Per Share
64.79
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
2.76B
Operating Revenue Per Share
23.72
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.18+0.1+1.97%879PE
BIAFbioAffinity Technologies0.303399+0.039899+15.14%-- 
DHRDanaher Corp201.77+0.67+0.33%38.97PE
TMOThermo Fisher Scientific426.565+5.095+1.21%24.72PE
PSNLPersonalis7.25+0.68+10.35%-- 
Quotes are at least 15-min delayed：2025/07/02 13:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includesimmunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.